ESMO Urges EU Competitiveness Council to Strengthen Clinical Research Ecosystem (esmo.org)

• ESMO calls on EU research ministers to adopt measures supporting clinical research innovation in oncology.
• Measures sought include streamlined regulations, increased funding, and better cross-border coordination.
• The policy directly impacts clinical trial capacity and medical innovation in Ireland.

"ESMO, the European Society for Medical Oncology, has called on EU research ministers ahead of a Competitiveness Council meeting to adopt measures that bolster the clinical research ecosystem in Europe. The organization emphasizes the need for innovation in oncology, including streamlined regulatory processes, increased funding, and better integration of clinical trials. These efforts aim to maintain Europe's competitiveness in medical research and ensure timely access to new cancer therapies. The statement has implications for Ireland, which relies on EU-wide policies for its clinical trial capacity and medical innovation."